La Jolla Pharmaceutical Company Stock OTC Bulletin Board
Equities
US5034596040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | La Jolla Pharmaceutical Announces Management Changes | CI |
2022 | La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index | CI |
Managers | Title | Age | Since |
---|---|---|---|
Michael Hearne
DFI | Director of Finance/CFO | 61 | 20-05-31 |
Tony Hodges
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-11 |
Luke Seikkula
COO | Chief Operating Officer | 60 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marianne Zhen
BRD | Director/Board Member | 55 | 22-08-21 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 22-08-21 |
1st Jan change | Capi. | |
---|---|---|
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.14% | 22.19B | |
-16.16% | 21.33B | |
-7.01% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |